Acute Kidney Damage in Patients Undergoing Open Heart Surgery
Is It Possible to Predict Acute Kidney Damage in Patients Undergoing Open Heart Surgery in the Preoperative Period?
1 other identifier
observational
88
1 country
1
Brief Summary
Aimed to determine whether preoperative biomarkers (Mg, Hgb, CRP, ProBNP) would be helpful in the early diagnosis of CSA-AKI (cardiac surgery-related acute kidney injury) in patients undergoing open heart surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 18, 2022
CompletedFirst Posted
Study publicly available on registry
June 21, 2022
CompletedStudy Start
First participant enrolled
September 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2024
CompletedJune 17, 2024
June 1, 2024
1.2 years
April 18, 2022
June 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The requirement of continue venovenous hemodiafiltration (CVVHDF)
After on pump surgery resulting AKI may require CVVHDF(pH\<7.21, urine output \< 0.5 ml/kg during 6 hours, potassium \> 6 mEq/L)
Immediately after surgery
Predict acute renal failure in on-pomp conary artery bypass via preoperative biomarkers
To detect acute kidney injury in the early period in open heart surgery and to take precautions
up to postoperative 28th day
Secondary Outcomes (1)
The requirement of hemodialysis during postoperative 28 days
up to postoperative 28th day
Study Arms (2)
Group I
At least two of the preoperative biomarkers (Mg\<0.85 mmol/L, Hgb\<8.5 mmol/L, proBNP\>480 pg/mL, CRP\>5 mg/L) that are thought to be closely related to acute kidney injury after cardiac surgery Group I,
Group II
Patients who meet at least two of the preoperative biomarkers (Mg\>0.85 mmol/L, Hgb\>8.5 mmol/L, proBNP\<480 pg/mL, CRP\<5 mg/L) Group II .
Interventions
In open heart surgery, it will be followed whether acute kidney injury will develop by looking at the biomarkers in the preoperative period.
Eligibility Criteria
Adult patients (aged ≥40 years,\<85 years) with ASA II-IV who were scheduled for elective open heart surgery under cardiopulmonary bypass (CPB) will be prospectively included in this study. Patients included in the study will be divided into two groups. At least two of the preoperative biomarkers (Mg\<0.85 mmol/L, Hgb\<8.5 mmol/L, proBNP\>480 pg/mL, CRP\>5 mg/L) that are thought to be closely related to acute kidney injury after cardiac surgery Group I, patients who meet at least two of the preoperative biomarkers (Mg\>0.85 mmol/L, Hgb\>8.5 mmol/L, proBNP\<480 pg/mL, CRP\<5 mg/L) Group II will be included in the study.
You may qualify if:
- Elective on-pomp coronary artery bypass
You may not qualify if:
- Emergency operation,
- Off pump coronary artery bypass
- Revision (repetitive) operation
- Preoperative acute Renal failure
- Preoperative chronic Renal failure
- Preoperative decompansed heart failure
- Valve replacement surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
BakirkoySadiKonuk Training and Searching Hospital
Istanbul, 34147, Turkey (Türkiye)
Related Links
Biospecimen
cystatin c level will be checked in the blood sample taken from the patient
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gülsüm Oya HERGÜNSEL, Ass. Prof.
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 4 Weeks
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 18, 2022
First Posted
June 21, 2022
Study Start
September 30, 2022
Primary Completion
November 30, 2023
Study Completion
May 30, 2024
Last Updated
June 17, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share